As of Feb 18, 2025, Chemed Corporation Intrinsic Value is $375.9. This suggests it may be overvalued by 32.0% compared to its current price of around $552.9.
As of Feb 18, 2025, Chemed Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $473.0. This suggests it may be overvalued by 14.4% to its current price of around $552.9, using a discount rate of 7.6% and terminal growth rate of 3.0%.
Chemed Corporation is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $375.9, compared to a market price of around $552.9. This suggests a potential overvaluation of 32.0%.